Cumberland Pharmaceuticals Correlations
CPIX Stock | USD 4.33 0.07 1.59% |
The correlation of Cumberland Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Cumberland Pharmaceuticals Correlation With Market
Significant diversification
The correlation between Cumberland Pharmaceuticals and DJI is 0.08 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Cumberland Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
Cumberland |
Moving together with Cumberland Stock
0.78 | AZN | AstraZeneca PLC ADR | PairCorr |
0.74 | LLY | Eli Lilly | PairCorr |
0.68 | OCX | OncoCyte Corp | PairCorr |
0.7 | SNY | Sanofi ADR | PairCorr |
0.81 | GILD | Gilead Sciences | PairCorr |
0.73 | GOSS | Gossamer Bio | PairCorr |
0.79 | AMGN | Amgen Inc | PairCorr |
Moving against Cumberland Stock
0.82 | IMRX | Immuneering Corp | PairCorr |
0.77 | IMMX | Immix Biopharma | PairCorr |
0.75 | VINC | Vincerx Pharma Earnings Call Tomorrow | PairCorr |
0.73 | MLTX | MoonLake Immunotherapeuti | PairCorr |
0.7 | ZURA | Zura Bio Limited | PairCorr |
0.66 | MRK | Merck Company | PairCorr |
0.64 | GPCR | Structure Therapeutics | PairCorr |
0.58 | ZVSA | ZyVersa Therapeutics | PairCorr |
0.53 | CDIOW | Cardio Diagnostics | PairCorr |
0.53 | ELVN | Enliven Therapeutics | PairCorr |
0.48 | ELEV | Elevation Oncology | PairCorr |
0.83 | PYXS | Pyxis Oncology | PairCorr |
0.8 | SCLX | Scilex Holding | PairCorr |
0.76 | ASMB | Assembly Biosciences Downward Rally | PairCorr |
0.73 | CGEM | Cullinan Oncology LLC | PairCorr |
0.73 | CMND | Clearmind Medicine Common | PairCorr |
0.69 | AVTE | Aerovate Therapeutics | PairCorr |
0.68 | RAIN | Rain Enhancement Tec | PairCorr |
0.67 | ATNF | 180 Life Sciences | PairCorr |
0.66 | CNSP | Cns Pharmaceuticals Earnings Call This Week | PairCorr |
0.53 | SONN | Sonnet Biotherapeutics | PairCorr |
0.52 | PHIO | Phio Pharmaceuticals Corp Earnings Call This Week | PairCorr |
0.51 | CRNX | Crinetics Pharmaceuticals | PairCorr |
0.5 | PMVP | Pmv Pharmaceuticals | PairCorr |
0.49 | BIIB | Biogen Inc | PairCorr |
0.4 | CDIO | Cardio Diagnostics | PairCorr |
0.4 | CELC | Celcuity LLC | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Cumberland Stock performing well and Cumberland Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Cumberland Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
EGRX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
RGC | 13.48 | 6.06 | 0.75 | (0.71) | 5.76 | 46.25 | 265.55 | |||
PROC | 6.35 | 0.04 | 0.00 | 0.00 | 8.25 | 7.98 | 96.00 | |||
IXHL | 4.37 | (1.33) | 0.00 | 2.72 | 0.00 | 8.33 | 30.31 | |||
PTPI | 8.92 | 0.10 | 0.01 | 0.02 | 10.98 | 14.29 | 72.24 | |||
EVOK | 3.20 | (0.74) | 0.00 | (0.70) | 0.00 | 6.85 | 30.53 | |||
AGRX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
PRFX | 4.58 | (0.85) | 0.00 | (0.48) | 0.00 | 6.69 | 40.81 | |||
SHPH | 4.54 | (0.96) | 0.00 | (5.52) | 0.00 | 9.41 | 28.76 | |||
MNK | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cumberland Pharmaceuticals Corporate Management
James Herman | Chief Compliance Officer and VP of National Accounts | Profile | |
John Hamm | Chief Officer | Profile | |
Christophe Bitterman | Vice Marketing | Profile | |
Todd Anthony | Vice Development | Profile | |
Adam Mostafa | Managing Relations | Profile | |
Erin Gull | Senior Associate | Profile |